Article
Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.
Pharmacogenetics and genomics - 1 Feb 2009
Kim Ho-Sook, Lee Sang Seop, Oh Minkyung, Jang Yin-Jin, Kim Eun-Young, Han Ii Yong, Cho Kwang-Hyun, Shin Jae-Gook
Abstract excerpt
OBJECTIVES: The effect of CYP2C9 and vitamin K epoxide reductase complex subunit 1 (VKORC1) genotypes was evaluated for the early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement. METHODS: The genotypes of CYP2C9 variants including CYP2C9*3, CYP2C9*13, and CYP2C9*14, and VKORC1 1173C>T were assessed for the association with warfarin dosing in 265 patients whose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
